Menu

Heidi Wang represents private and public companies in a wide range of corporate and securities matters, including private financings, mergers and acquisitions, public offerings, SEC reporting and compliance and corporate governance. 

Download full bio 

Experience

  • Poseida Therapeutics – $80.5 Million Follow-on Offering 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

Education

  • University of California at Irvine School of Law
    JD, magna cum laude, 2020

  • Cornell University
    BA, Economics
    2014


Admissions & Credentials

California